<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <sec id="FPar3">
  <title>Ethics approval and consent to participate</title>
  <p id="Par47">This study was approved by the Ethics Committee on Human Research of the Nanjing Drum Tower Hospital (No. 201406401). Patients were assessed for eligibility between November 2014 and February 2015 (NCT 02313415). Informed consent for the cell therapy performed in the current study was obtained from every patient. The human newborn umbilical cord tissues used in this study were obtained from the 306th Hospital (Beijing, China) and cultured by the Institute of Zoology, Chinese Academy of Sciences (Beijing, China). No tissues were obtained from prisoners.</p>
 </sec>
 <sec id="FPar4">
  <title>Consent for publication</title>
  <p id="Par48">Consent for publication was also obtained from every patient.</p>
 </sec>
 <sec id="FPar5">
  <title>Competing interests</title>
  <p id="Par49">The authors declare that they have no competing interests.</p>
 </sec>
 <sec id="FPar6">
  <title>Publisher's Note</title>
  <p id="Par50">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
 </sec>
</notes>
